Ireland
--:--IST
Latest
Clinical Trials in Czechia / NCT07130851
Active, not recruiting Not applicable

Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma

NCT07130851 · tracked via the Priya Life Science Czechia tracker
Sponsor
Marketa Bonaventurova
Phase
Not applicable
Started
2025-06-01
Last updated
2025-08-19

Condition(s) studied

Vestibular SchwannomaUnilateral Vestibular DeficitHealthy

Investigational drug(s) / intervention(s)

vestibular schwannoma resection

vestibular schwannoma resection: Vestibular schwannoma resection leads to partial or combined acute unilateral peripheral or combined vestibular lesion.The organism responds with the process of central vestibular compensation.

Study summary

The goal of this clinical trial is to visualize the possible activation of vestibular centers in the brain using in patiens with unilateral vestibular damage, specifically in patients after vestibular schwannoma surgery.

The main questions it aims to answer are:

1. Is there a difference in the proces sof activation of vestibular centers in patients with unilateral vestibular disorder and healthy subjects.
2. Are we able to effect this activation with our postoperative treatment? Researchers will compare the obtained results between patients with unilateral vestibular disorder and healthy controls.

Participants will be asked to fill out the set of questionaires, to undergo clinical objective vestibular examnation and examination in magnetic resonance.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * vestibular schwannoma Exclusion Criteria: * claustrophobia, visual impairment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Otorhinolaryngology and Head and Neck Surgery, 1st Medical Faculty Charles University and University Hospital Motol Prague Czechia

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07130851 on ClinicalTrials.gov ↗ ← All trials in Czechia